CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia

138Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

At a children's hospital in Riga, Latvia, isolates identified as Salmonella typhimurium were found to be resistant to expanded-spectrum cephalosporins. Two of the resistant strains were analyzed for the mechanism of cephalosporin resistance. Isoelectric focusing revealed a common β- lactamase with a pI of 8.8. In addition, one of the strains produced a pI 7.6 β-lactamase. A transconjugant producing only the pI 7.6 enzyme was susceptible to expanded-spectrum cephalosporins; therefore, this enzyme was most likely SHV-1. Transformants producing only the pI 8.8 β-lactamase were resistant to cefotaxime and aztreonam but were susceptible or intermediate to ceftazidime. A substrate profile determined spectrophotometrically with purified enzyme revealed potent activity against cefotaxime, with a relative k(cat) value of 95 (benzylpenicillin equal to 100). The enzyme showed lower relative k(cat) values for ceftazidime (3.3) and aztreonam (9.3). In addition, the enzyme was inhibited by clavulanate, sulbactam and tazobactam, with 50% inhibitory concentrations of 19, 100, and 3.4 nM, respectively. These results indicated the presence of an unusual extended-spectrum β- lactamase. The gene expressing the pI 8.8 β-lactamase was cloned. Nucleotide sequencing revealed a β-lactamase gene that differs from the gene encoding CTX-M-2, which also originated from S. typhimurium, by 11 nucleotides, 4 of which result in amino acid substitutions: Ala27Thr, Val230Gly, Glu254Ala, and Ile278Val. These results indicated the presence of a novel extended-spectrum β-lactamase, designated CTX-M-5, that specifically confers resistance to cefotaxime.

References Powered by Scopus

8657Citations
4012Readers
Get full text

This article is free to access.

Get full text

Cited by Powered by Scopus

2872Citations
2394Readers

This article is free to access.

This article is free to access.

1321Citations
1066Readers

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bradford, P. A., Yang, Y., Sahm, D., Grope, I., Gardovska, D., & Storch, G. (1998). CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrobial Agents and Chemotherapy, 42(8), 1980–1984. https://doi.org/10.1128/aac.42.8.1980

Readers over time

‘12‘13‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 17

74%

Researcher 6

26%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 9

33%

Immunology and Microbiology 9

33%

Biochemistry, Genetics and Molecular Bi... 6

22%

Medicine and Dentistry 3

11%

Save time finding and organizing research with Mendeley

Sign up for free
0